Who are the top shareholders of the UltraTech Cem.?

The top shareholders of UltraTech Cement are Grasim Industries Limited with 56.11%, followed by institutional investors with 28.95% (including 122 mutual fund schemes at 13.78% and 924 foreign institutional investors at 15.17%). The Life Insurance Corporation of India is the largest public shareholder at 2.45%, while individual investors hold about 5.37%.

The top shareholders of UltraTech Cement include Grasim Industries Limited, which holds the largest stake at 56.11%. Other significant shareholders are institutional investors, with 122 mutual fund schemes collectively holding 13.78% and 924 foreign institutional investors (FIIs) holding 15.17%. The highest public shareholder is the Life Insurance Corporation of India, with a stake of 2.45%. Individual investors also hold about 5.37% of the company.

When is the next results date for UltraTech Cem.?

No Upcoming Board Meetings

What does UltraTech Cem. do?

UltraTech Cement Ltd is a large-cap company in the Cement & Cement Products industry, originally established as L&T Cement Limited in 2000 and renamed in 2004. As of March 2025, it reported net sales of ₹23,063 Cr and a net profit of ₹2,482 Cr.

Overview: <BR>UltraTech Cement Ltd operates in the Cement & Cement Products industry and is classified as a Large Cap company.<BR><BR>History: <BR>The company was incorporated on August 24, 2000, originally as L&T Cement Limited, a 100% subsidiary of Larsen & Toubro Limited. It underwent a name change to UltraTech Chem Co. Limited in November 2003, and after Grasim Industries Ltd acquired management control in July 2004, it was renamed UltraTech Cement Limited on October 14, 2004. The latest quarterly results reported net sales and net profit for the period ending March 2025.<BR><BR>Financial Snapshot: <BR>Net Sales: 23,063 Cr (Quarterly Results - Mar 2025) <BR>Net Profit: 2,482 Cr (Quarterly Results - Mar 2025) <BR>Market Cap: Rs 331,943 Cr (Large Cap)<BR><BR>Key Metrics: <BR>P/E: 52.00 <BR>Industry P/E: 46 <BR>Dividend Yield: 0.61% <BR>Debt-Equity: 0.28 <BR>Return on Equity: 8.97% <BR>Price to Book: 4.65<BR><BR>Contact Details: <BR>Address: B Wing Ahura Centre 2nd Flr, Mahakali Caves Road Andheri(E) Mumbai Maharashtra : 400093 <BR>Tel: 91-22-66917800 <BR>Email: sharesutcl@adityabirla.com <BR>Website: http://www.ultratechcement.com

Has UltraTech Cem. declared dividend?

Yes, UltraTech Cement Ltd has declared a 700% dividend, amounting to ₹70 per share, with an ex-date of July 30, 2024. The company has shown positive total returns over various periods, particularly strong over the long term.

UltraTech Cement Ltd has declared a 700% dividend.<BR><BR>Dividend Details:<BR>- Percentage announced: 700%<BR>- Amount per share: 70<BR>- Ex-date: 30 Jul 24<BR><BR>Dividend Yield: 0.61%.<BR><BR>Total Returns by Period:<BR>In the last 6 months, the price return was -5.34%, with no dividend return, resulting in a total return of -5.34%.<BR><BR>Over the past year, the price return was 11.53%, with a dividend return of 0.64%, leading to a total return of 12.17%.<BR><BR>In the 2-year period, the price return was 38.51%, with a dividend return of 1.31%, culminating in a total return of 39.82%.<BR><BR>For the 3-year period, the price return was 101.09%, with a dividend return of 2.70%, resulting in a total return of 103.79%.<BR><BR>In the last 4 years, the price return was 68.46%, with a dividend return of 2.66%, giving a total return of 71.12%.<BR><BR>Over the past 5 years, the price return was 189.95%, with a dividend return of 5.01%, leading to a total return of 194.96%.<BR><BR>Overall, UltraTech Cement Ltd has declared a significant dividend, and the total returns over various periods indicate a positive trend, particularly over the longer term, with substantial price appreciation and increasing dividend contributions.

Who are the peers of the UltraTech Cem.?

UltraTech Cem.'s peers include Grasim Inds, Ambuja Cements, Shree Cement, J K Cements, Dalmia Bharat Ltd, ACC, The Ramco Cement, Nuvoco Vistas, Birla Corpn., and JK Lakshmi Cem. J K Cements has the highest 1-year return at 36.66%, while ACC has the lowest at -30.08%, with UltraTech Cem. returning 5.66%.

Peers: The peers of UltraTech Cem. are Grasim Inds, Ambuja Cements, Shree Cement, J K Cements, Dalmia BharatLtd, ACC, The Ramco Cement, Nuvoco Vistas, Birla Corpn., and JK Lakshmi Cem.<BR><BR>Quality Snapshot: Excellent management risk is observed at Grasim Inds, Shree Cement, J K Cements, ACC, and JK Lakshmi Cem., while Average management risk is found at Ambuja Cements, Dalmia BharatLtd, The Ramco Cement, Nuvoco Vistas, Birla Corpn., and the rest. Good growth is noted at Grasim Inds, while Average growth is seen at UltraTech Cem., Ambuja Cements, Shree Cement, J K Cements, Dalmia BharatLtd, ACC, The Ramco Cement, Nuvoco Vistas, Birla Corpn., and the rest. Good capital structure is present at UltraTech Cem., Dalmia BharatLtd, and JK Lakshmi Cem., while Excellent capital structure is noted at Ambuja Cements, Shree Cement, and ACC.<BR><BR>Return Snapshot: The peer with the highest 1-year return is J K Cements at 36.66%, while the lowest is ACC at -30.08%, with UltraTech Cem.'s own return at 5.66% being higher than ACC's but lower than J K Cements'. Additionally, the peers with negative six-month returns include ACC, The Ramco Cement, and Nuvoco Vistas.

Is UltraTech Cem. overvalued or undervalued?

As of May 22, 2024, UltraTech Cement is considered very expensive and overvalued with a PE Ratio of 52.27 and an EV to EBITDA of 27.92, significantly higher than its peers like Grasim Industries and Ambuja Cements, and it has underperformed the Sensex over the past year.

As of 22 May 2024, UltraTech Cement's valuation grade has moved from expensive to very expensive, indicating a significant shift in its market perception. The company is currently considered overvalued. Key ratios include a PE Ratio of 52.27, an EV to EBITDA of 27.92, and a Price to Book Value of 4.69, all of which are considerably higher than industry norms.<BR><BR>In comparison to peers, Grasim Industries, which is rated attractive, has a PE Ratio of 43.9 and an EV to EBITDA of 11.89, while Ambuja Cements, rated expensive, has a PE Ratio of 32.77 and an EV to EBITDA of 21.70. These comparisons highlight UltraTech's premium valuation relative to its competitors. Additionally, while UltraTech's stock has shown a 7.03% return over the past year, it has underperformed the Sensex, which returned 7.57% in the same period, further supporting the notion of overvaluation.

Who are in the management team of UltraTech Cem.?

As of March 2023, the management team of UltraTech Cement includes Kumar Mangalam Birla (Chairman), K C Jhanwar (Managing Director), and Atul Daga (CFO), along with several non-executive and independent directors. They oversee the company's strategic direction and governance.

As of March 2023, the management team of UltraTech Cement includes the following members:<BR><BR>1. Kumar Mangalam Birla - Chairman (Non-Executive)<BR>2. Rajashree Birla - Non-Executive & Non-Independent Director<BR>3. S K Chatterjee - Company Secretary & Compliance Officer<BR>4. S B Mathur - Non-Executive & Independent Director<BR>5. Arun Adhikari - Non-Executive & Independent Director<BR>6. Sukanya Kripalu - Non-Executive & Independent Director<BR>7. KrishnaKishore Maheshwari - Vice Chairman & Non-Executive<BR>8. Alka Bharucha - Non-Executive & Independent Director<BR>9. Atul Daga - Whole Time Director & CFO<BR>10. K C Jhanwar - Managing Director<BR>11. Sunil Duggal - Non-Executive & Independent Director<BR><BR>This team is responsible for the strategic direction and governance of the company.

Are UltraTech Cem. latest results good or bad?

UltraTech Cement's latest results show strong profitability growth, with a 47.42% increase in Profit Before Tax and a 34.9% rise in Profit After Tax. However, rising interest expenses and declining inventory turnover raise concerns about liquidity and borrowing costs.

UltraTech Cement's latest results present a mixed picture. On one hand, the company has shown impressive growth in profitability, with a Profit Before Tax (PBT) of Rs 2,865.95 crore, up 47.42% year-on-year, and a Profit After Tax (PAT) of Rs 2,254.24 crore, reflecting a 34.9% increase. Additionally, net sales grew by 13.06%, indicating a positive trend in revenue generation.<BR><BR>However, there are notable challenges as well. Interest expenses have surged to Rs 1,365.09 crore, a significant increase of 63.71%, which raises concerns about higher borrowing costs. The inventory turnover ratio has declined to 7.80 times, the lowest in recent periods, suggesting slower inventory sales. Furthermore, the debt-equity ratio has reached its highest point in five half-yearly periods at 0.34 times, indicating increased borrowing, and the debtors turnover ratio has also decreased, pointing to slower collection of receivables.<BR><BR>In summary, while UltraTech Cement's profitability metrics are strong and show substantial growth, the rising costs and liquidity concerns present challenges that the company will need to address moving forward.

How big is UltraTech Cem.?

As of 24th July, UltraTech Cement Ltd has a market capitalization of 362,376.00 Cr and reported net sales of 77,752.33 Cr and net profit of 6,887.41 Cr over the latest four quarters.

As of 24th July, <BR><BR>Market Cap: UltraTech Cement Ltd has a market capitalization of 362,376.00 Cr, classified as Large Cap.<BR><BR>Recent Quarterly Performance: The sum of Net Sales for the latest 4 quarters is 77,752.33 Cr, while the sum of Net Profit for the same period is 6,887.41 Cr.<BR><BR>Balance Sheet Snapshot: The reporting period is March 2024, with Shareholder's Funds amounting to 60,227.48 Cr and Total Assets valued at 1,00,797.11 Cr.

How has been the historical performance of UltraTech Cem.?

UltraTech Cement has shown consistent growth in net sales, increasing from INR 41,608.81 crore in March 2019 to INR 75,955.13 crore in March 2025, though profit margins have fluctuated, with profit after tax peaking at INR 7,005.00 crore in March 2024 before declining to INR 6,039.11 crore in March 2025. Total liabilities and assets have also risen significantly during this period, while cash flow from operating activities has decreased.

Answer:<BR>The historical performance of UltraTech Cem. shows a consistent growth trend in net sales and profits over the years, with some fluctuations in profit margins.<BR><BR>Breakdown:<BR>UltraTech Cem. has demonstrated a steady increase in net sales from INR 41,608.81 crore in March 2019 to INR 75,955.13 crore in March 2025. This growth is reflected in total operating income, which rose from INR 41,608.81 crore in March 2019 to INR 75,955.13 crore in March 2025. However, the total expenditure has also increased significantly, reaching INR 63,397.68 crore in March 2025, up from INR 34,261.87 crore in March 2019. Operating profit (PBDIT) has shown fluctuations, peaking at INR 13,585.51 crore in March 2024 before declining to INR 13,301.62 crore in March 2025. Profit before tax reached INR 9,400.21 crore in March 2024 but fell to INR 7,538.70 crore in March 2025. Profit after tax followed a similar trend, with a peak of INR 7,005.00 crore in March 2024, dropping to INR 6,039.11 crore in March 2025. The earnings per share (EPS) also fluctuated, with a high of 254.42 in March 2022 and a decrease to 204.94 in March 2025. On the balance sheet, total liabilities increased from INR 79,213.81 crore in March 2020 to INR 1,33,632.06 crore in March 2025, while total assets rose from INR 79,213.81 crore to INR 1,33,632.06 crore in the same period. Cash flow from operating activities showed a decline from INR 12,500 crore in March 2021 to INR 10,673 crore in March 2025, indicating a tightening cash position despite the growth in sales.

Is UltraTech Cem. technically bullish or bearish?

As of December 3, 2025, UltraTech Cement's trend has shifted to mildly bearish, driven by bearish signals from weekly MACD and KST, despite mildly bullish daily moving averages, and underperformance compared to the Sensex.

As of 3 December 2025, the technical trend for UltraTech Cement has changed from mildly bullish to mildly bearish. The current stance is mildly bearish. Key indicators driving this include the weekly MACD and KST both showing bearish signals, while the monthly MACD and KST are mildly bearish as well. The Dow Theory also indicates a mildly bearish trend on both weekly and monthly time frames. Although the daily moving averages are mildly bullish, they are overshadowed by the overall bearish sentiment in the weekly indicators. The stock has underperformed compared to the Sensex over the past month and year, further supporting the bearish outlook.

Should I buy, sell or hold UltraTech Cem.?

Which are the latest news on UltraTech Cem.?

Why is UltraTech Cem. falling/rising?

As of 18-Dec, UltraTech Cement Ltd's stock price is at 11,460.45, down 0.65%, with a bearish trend indicated by declines over 1 month and 1 year, and reduced investor participation. Despite strong debt servicing and sales growth, the stock's valuation appears high, contributing to its negative returns.

As of 18-Dec, UltraTech Cement Ltd's stock price is falling, currently at 11,460.45, reflecting a decrease of 75.2 points or 0.65%. This decline is evident in the stock's performance over various periods, such as a 1-month decrease of 2.10% and a 1-year decline of 2.68%, while the benchmark Sensex has shown positive returns in the same timeframe. <BR><BR>The stock is trading below its moving averages across multiple time frames, indicating a bearish trend. Additionally, there has been a significant drop in investor participation, with delivery volume falling by 25.5% compared to the 5-day average. This reduced activity suggests a lack of confidence among investors.<BR><BR>Despite some positive factors, such as strong debt servicing ability and healthy long-term growth in net sales, the stock's valuation appears expensive with a return on capital employed (ROCE) of 11.4 and a PEG ratio of 3.5. Furthermore, while profits have increased by 15.4% over the past year, the stock has generated negative returns, contributing to its current downward trajectory.